Expressive Writing and Adjustment to Metastatic Breast Cancer
N/A
18 Years
N/A
18 Years
N/A
Not Enrolling
Female
Metastatic Breast Cancer
Female
Metastatic Breast Cancer
Trial Information
Expressive Writing and Adjustment to Metastatic Breast Cancer
Inclusion Criteria:
- Women with Stage IV breast cancer
- Receiving cancer care at Memorial Sloan-Kettering Cancer Center
- At least 18 years of age
- Can speak, read, and write in English
- In the judgment of consenting professionals able to provide informed consent
- Score of 4 or higher on the distress thermometer (established cutoff score for
probable distress; see Jacobsen et al., 2005)
Exclusion Criteria:
- Significant psychiatric or cognitive impairment (dementia/delirium, retardation,
psychosis) that in the judgment of the investigators will preclude providing informed
consent and participating in the intervention
- Currently engaging in expressive writing (e.g., journal writing that involves
expressing one's feelings) on a daily basis
- Currently participating in intervention trials with similar endpoints • Male
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Determine the potential utility of expressive writing for enhancing existential well-being (i.e., increasing a sense of meaning and peace and reducing demoralization) among women with metastatic breast cancer.
Outcome Time Frame:
conclusion of the study
Safety Issue:
No
Principal Investigator
Katherine DuHamel, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Memorial Sloan-Kettering Cancer Center
Authority:
United States: Institutional Review Board
Study ID:
08-011
NCT ID:
NCT00624156
Start Date:
February 2008
Completion Date:
January 2012
Related Keywords:
- Metastatic Breast Cancer
- Breast Cancer
- Breast Neoplasms
Name | Location |
|---|---|
| Memorial Sloan Kettering Cancer Center | New York, New York 10021 |
